stars 1 stars 2 stars 3

NuChem Sciences a CRO specialized in preclinical drug discovery, offering standalone & integrated services. We Transform Ideas Through Science. Since August 2023, NuChem Sciences is now a Sygnature Discovery business.

NuChem Sciences Questions

The NuChem Sciences annual revenue was $43.3 million in 2026.

Malken Bayrakdarian is the Vice President, Drug Discovery of NuChem Sciences.

31 people are employed at NuChem Sciences.

NuChem Sciences is based in Montreal, Quebec.

Top NuChem Sciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users